Biography
As the principal investigator in the iMED (Innovative Medical Engineering Developments) lab, Sejdic aims for iMED to become an international leader in dynamical biomarkers indicative of age- and disease-related changes and their contributions to functional decline under normal and pathological conditions.
In particular, he strives to develop clinically relevant solutions to such problems by fostering innovation in computational approaches and instrumentation that can be translated to bedside care.